Article Details

SUDA Pharmaceuticals Proposed Share Consolidation for Effective Capital Structure

Retrieved on: 2019-10-16 15:18:45

Tags for this article:

Click the tags to see associated articles and topics

SUDA Pharmaceuticals Proposed Share Consolidation for Effective Capital Structure. View article details on hiswai:

Excerpt

<div>SUDA holds a robust product pipeline, which includes an FDA-approved insomnia drug and several other drugs in its <b>research</b> pipeline.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up